Solesence, Inc.
SLSNSolesence, Inc. in brief
Solesence, Inc. is a listed company in the FMCG industry, based in Romeoville, Illinois, USA. Its market value was $59 M on 30 October 2026, which makes it the 20,733rd largest listed company in the world and the 3,790th largest in the USA on this site. In the year to December 2025 it had sales of $62 M and a net profit of $3 M, about 5 cents of profit for every dollar of sales. It employs about 115 people. Its largest product and service lines by sales in 2025 were Consumer Products (88%), Personal Care ingredients (10%) and Advanced Materials (1%). Its shares trade under the symbol SLSN (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Solesence, Inc. timeline
- 1997
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2025
- 💰Record revenue of $62 millionFY2025, the highest of the 8 years on record.
- 💰Record net income of $3 millionFY2025, the highest profit of the 4 years on record.
- ✎Renamed Solesence, Inc.Formerly Nanophase Technologies Corporation.
Events of Solesence, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #3,679 (Oct 2026) · #3,794 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- 21.3×
- Price / sales (TTM)
- 1.0×
- Price / book
- 4.2×
- Free cash flow yield
- -4.4%
- Net margin (TTM)
- 4.5%
- Operating margin
- 4.2%
- Return on equity
- 19.6%
- Liabilities / assets
- 69.8%
- Net debt
- $-1M
- Revenue growth
- +18.5%
- R&D / revenue
- 6.6%
- Revenue per employee
- $540 K
- Profit per employee
- $24 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $62M | +18.5% | $3M | $3M | 4.5% |
| Dec 2024 | $52M | +40.3% | $2M | $1M | 2.1% |
| Dec 2023 | $37M | -0.1% | $-4M | $-5M | -13.2% |
| Dec 2022 | $37M | +26.6% | $-2M | $-3M | -7.0% |
| Dec 2021 | $29M | +72.2% | $3M | $2M | 7.9% |
| Dec 2020 | $17M | +36.9% | $1M | $1M | 5.8% |
| Dec 2019 | $13M | -11.8% | $-3M | $-3M | -24.1% |
| Dec 2018 | $14M | — | $-2M | $-2M | -14.7% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-9M | — | — | $0.04 | — |
| Dec 2024 | $2M | $5M | $-3M | $0.02 | — |
| Dec 2023 | $-2M | $1M | $-3M | $-0.10 | — |
| Dec 2022 | $-2M | $3M | $-4M | $-0.05 | — |
| Dec 2021 | $2M | $2M | $0M | $0.05 | — |
| Dec 2020 | $-2M | $1M | $-3M | $0.03 | — |
| Dec 2019 | $-3M | $1M | $-4M | $-0.08 | — |
| Dec 2018 | $-1M | $0M | $-2M | $-0.06 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $20M (+38.1% on a year earlier), net income $4M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 12, 202610-QQuarterly report · period to Sep 2026
- Nov 12, 20268-KCurrent reportResults of operations
- Nov 10, 202610-Q/AQuarterly report (amended) · period to Jun 2026
- Nov 10, 202610-Q/AQuarterly report (amended) · period to Mar 2026
- Nov 10, 202610-Q/AQuarterly report (amended) · period to Sep 2025
- Nov 10, 202610-K/AAnnual report (amended) · period to Dec 2025
- Nov 10, 202610-K/AAnnual report (amended) · period to Dec 2024
- Oct 5, 20268-KCurrent reportMaterial agreement
- Oct 2, 20268-KCurrent reportListing notice
- Aug 21, 20268-KCurrent reportRestatement
- Aug 20, 20268-KCurrent reportResults of operations
- Aug 19, 202610-QQuarterly report · period to Jun 2026
Official filings of Solesence, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $62 M
- Operating income
- $3 M
- Net income
- $3 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $46 M
- Total liabilities
- $32 M
- Total equity
- $14 M
As of December-2025
Top 34 institutional investors in Solesence, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | Vanguard Capital Management LLC | 813,998 | -16,510 (-1.99%) | 1.15% | $1 M | Nov 13, 2026 |
| 2 | BlackRock, Inc. | 326,762 | -136,890 (-29.52%) | 0.46% | $0 M | Nov 13, 2026 |
| 3 | Bank of New York Mellon Corp | 317,609 | 0 (0.00%) | 0.45% | $0 M | Nov 5, 2026 |
| 4 | Millennium Management LLC | 262,524 | -13,973 (-5.05%) | 0.37% | $0 M | Nov 16, 2026 |
| 5 | Geode Capital Management, LLC | 229,297 | -9,217 (-3.86%) | 0.32% | $0 M | Nov 6, 2026 |
| 6 | Morgan Stanley | 185,915 | -2,882 (-1.53%) | 0.26% | $0 M | Nov 13, 2026 |
| 7 | Donaldson Capital Management, LLC | 150,000 | 0 (0.00%) | 0.21% | $0 M | Nov 9, 2026 |
| 8 | Susquehanna International Group, LLP | 113,202 | +1,862 (+1.67%) | 0.16% | $0 M | Nov 16, 2026 |
| 9 | Vanguard Fiduciary Trust Co | 106,692 | 0 (0.00%) | 0.15% | $0 M | Nov 13, 2026 |
| 10 | Jane Street Group, LLC | 60,815 | -38,570 (-38.81%) | 0.09% | $0 M | Nov 12, 2026 |
| 11 | Northern Trust Corp | 36,932 | 0 (0.00%) | 0.05% | $0 M | Nov 16, 2026 |
| 12 | Zacks Investment Management | 27,955 | -10,000 (-26.35%) | 0.04% | $0 M | Nov 16, 2026 |
| 13 | Wealth Enhancement Advisory Services, LLC | 22,076 | -682 (-3.00%) | 0.03% | $0 M | Oct 13, 2026 |
| 14 | Barclays PLC | 19,048 | -759 (-3.83%) | 0.03% | $0 M | Nov 6, 2026 |
| 15 | Qube Research & Technologies Ltd | 15,239 | -6,799 (-30.85%) | 0.02% | $0 M | Nov 13, 2026 |
| 16 | XTX Topco Ltd | 14,392 | New | 0.02% | $0 M | Nov 16, 2026 |
| 17 | State Street Corp | 14,050 | -4,100 (-22.59%) | 0.02% | $0 M | Nov 12, 2026 |
| 18 | Tower Research Capital LLC (TRC) | 5,417 | -49,858 (-90.20%) | 0.01% | $0 M | Nov 16, 2026 |
| 19 | Royal Bank Of Canada | 5,190 | +632 (+13.87%) | 0.01% | $0 M | Nov 16, 2026 |
| 20 | Provenance Wealth Advisors, LLC | 2,000 | New | 0.00% | $0 M | Oct 30, 2026 |
| 21 | Wells Fargo & Company/mn | 1,575 | -13 (-0.82%) | 0.00% | $0 M | Nov 16, 2026 |
| 22 | BNP Paribas Financial Markets | 1,516 | -127 (-7.73%) | 0.00% | $0 M | Nov 12, 2026 |
| 23 | Vanguard Global Advisers, LLC | 1,200 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
| 24 | Osaic Holdings, Inc. | 1,000 | 0 (0.00%) | 0.00% | $0 M | Nov 12, 2026 |
| 25 | UBS Group AG | 754 | +680 (+918.92%) | 0.00% | $0 M | Nov 10, 2026 |
Show all 34: investors 26 to 34
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Jpmorgan Chase & Co | 548 | 0 (0.00%) | 0.00% | $0 M | Nov 12, 2026 |
| 27 | Russell Investments Group, Ltd. | 300 | -1,101 (-78.59%) | 0.00% | $0 M | Nov 6, 2026 |
| 28 | FMR LLC | 225 | -17 (-7.02%) | 0.00% | $0 M | Nov 10, 2026 |
| 29 | Citigroup Inc | 18 | -5,677 (-99.68%) | 0.00% | $0 M | Nov 4, 2026 |
| 30 | Arax Advisory Partners | 14 | -311 (-95.69%) | 0.00% | $0 M | Nov 12, 2026 |
| 31 | Allworth Financial LP | 7 | -43 (-86.00%) | 0.00% | $0 M | Nov 17, 2026 |
| 32 | Rothschild Investment LLC | 1 | -15 (-93.75%) | 0.00% | $0 M | Nov 10, 2026 |
| 33 | IFP Advisors, Inc | 1 | -10 (-90.91%) | 0.00% | $0 M | Oct 16, 2026 |
| 34 | Essential Partners LLC | 1 | -46 (-97.87%) | 0.00% | $0 M | Oct 14, 2026 |
Mutual funds holding Solesence, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 597,505 | $0 M | 0.85% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 205,663 | $0 M | 0.29% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 96,187 | $0 M | 0.14% | <0.01% | +4.0% | May 31, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 95,662 | $0 M | 0.14% | <0.01% | −0.8% | May 31, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 68,221 | $0 M | 0.10% | <0.01% | +39% | Jun 30, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 40,284 | $0 M | 0.06% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 63,629 | $0 M | 0.09% | <0.01% | −81% | Jun 30, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 31,985 | $0 M | 0.05% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 25,503 | $0 M | 0.04% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 18,234 | $0 M | 0.03% | <0.01% | +3.0% | May 31, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 27,689 | $0 M | 0.04% | <0.01% | −80% | Jun 30, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 18,797 | $0 M | 0.03% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company | 7,648 | $0 M | 0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 8,543 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 7,017 | $0 M | <0.01% | <0.01% | −78% | Jun 30, 2026 |
| 🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION | 4,100 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 3,959 | $0 M | <0.01% | <0.01% | −80% | Jun 30, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 3,821 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC | 3,513 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc. | 1,397 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC | 886 | $0 M | <0.01% | <0.01% | +9.0% | May 31, 2026 |
| 🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC | 692 | $0 M | <0.01% | <0.01% | −40% | May 31, 2026 |
| 🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC | 694 | $0 M | <0.01% | <0.01% | −40% | May 31, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 960 | $0 M | <0.01% | <0.01% | −80% | Jun 30, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 832 | $0 M | <0.01% | <0.01% | −87% | Jun 30, 2026 |
| 🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 613 | $0 M | <0.01% | <0.01% | −80% | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 683 | $0 M | <0.01% | <0.01% | −80% | Jun 30, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 488 | $0 M | <0.01% | <0.01% | −78% | Jun 30, 2026 |
| 🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC | 131 | $0 M | <0.01% | <0.01% | −79% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 106 | $0 M | <0.01% | <0.01% | +16% | Jun 30, 2026 |
| 🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC | 105 | $0 M | <0.01% | <0.01% | +7.1% | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 31 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Solesence, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | R. Janet WhitmoreDirector | Buy | +1,500 | $1.910 | $3 K | 2.09 M | Form 4 |
| filed | R. Janet WhitmoreDirector | Buy | +1,000 | $1.920 | $2 K | 2.09 M | Form 4 |
| filed | R. Janet WhitmoreDirector | Buy | +5,000 | $1.950 | $10 K | 2.08 M | Form 4 |
| filed | R. Janet WhitmoreDirector | Buy | +5,000 | $1.890 | $9 K | 2.08 M | Form 4 |
| filed | R. Janet WhitmoreDirector | Buy | +267 | $1.830 | $489 | 2.07 M | Form 4 |
| filed | R. Janet WhitmoreDirector | Buy | +5,000 | $1.870 | $9 K | 2.07 M | Form 4 |
| filed | R. Janet WhitmoreDirector | Buy | +19,789 | $1.730 | $34 K | 2.07 M | Form 4 |
| filed | Kevin CuretonChief Operating Officer | Option exercise | +38,807 | $0.420 | $16 K | 231,019 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Solesence, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Trading halts
- 2025-04-08 14:39 UTC, code LUDP, resumed 14:44 UTC
- 2025-04-08 14:26 UTC, code LUDP, resumed 14:36 UTC
- 2025-04-08 13:30 UTC, code LUDP, resumed 14:25 UTC
Fails to deliver
- : 23 shares at $0.83
- : 1,195 shares at $0.80
- : 2,784 shares at $1.00
- : 5,109 shares at $0.81
- : 219 shares at $0.85
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Solesence, Inc. scorecard#
Passes 13 of the 20 checks that could be worked out: strongest in growth (6 of 6), weakest in financial health (1 of 3). Fiscal year 2025; market cap of Oct 30, 2026.
Valuation3 of 5
- ✓P/E below its peers' median21.3×P/E 21.3× against FMCG's median of 23.2×.
- ✓Price to book below its peers' median4.2×Price to book 4.2× against FMCG's median of 5.1×.
- ✓Price to sales below its peers' median1.0×Price to sales 1.0× against FMCG's median of 2.5×.
- ✗Free cash flow yield above 5%-4.4%Free cash flow is -4.4% of the market value.
- ✗Earnings yield above the 10-year Treasury yield4.7%Earnings yield 4.7% against the 10-year Treasury's 5.15% on 2026-11-13.
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth6 of 6
- ✓Revenue grew in the newest year18.6%Revenue up 18.6% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years18.5%18.5% a year over the three years to fiscal 2025.
- ✓Faster growth over three years than its peers' median18.5%18.5% a year against FMCG's median of 0.4% (30 companies).
- ✓Earnings per share grew in the newest year0.04 vs 0.02Diluted EPS 0.04 in fiscal 2025 against 0.02 the year before (report's currency).
- ✓Net income higher than five years earlier$3 M$3 M in fiscal 2025 against $1 M in 2020.
- ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
Profitability3 of 5
- ✓Profitable in the newest year$3 MNet income $3 M in fiscal 2025.
- ✗Profitable in each of the last five years3 of 5Profitable in 3 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median4.2%4.2% against FMCG's median of 5.3% (40 companies).
- ✓Return on equity above 15%23.1%23.1% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier4.2%4.2% in fiscal 2025 against -6.1% in 2022.
Financial health1 of 3
- ✓Short-term assets cover short-term liabilities1.8×Current ratio 1.80 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years1 of 3Positive in 1 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone-0.19Z-score -0.19 (distress zone) for fiscal 2025.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year11.6%Diluted shares up 11.6% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.
Worked out from the statements as filed (sec), the medians of FMCG, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Solesence, Inc.'s statements, beside the median of FMCG.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | 4.2% | 5.3% | |
| Net margin | 4.5% | 4.1% | |
| Return on equity | 23.1% | 11.2% | |
| Revenue growth, 3 years a year | 18.5% | 0.4% | |
| Revenue growth | 18.6% | 1.4% |
5of 8on the Piotroski tests of financial strength
- Only -305% of net income arrived as cash from operations.
- The share count rose 11.6% in the year.
- Receivables grew 40% while revenue grew 19%: customers are paying later, or sales were booked ahead of cash.
Solesence, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 | FY 2018to Dec 31, 2018 | FY 2017to Dec 31, 2017 | FY 2016to Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 62+18.6%100% | 52+40.4%100% | 37−0.1%100% | 37+26.6%100% | 29+72.1%100% | 17+36.9%100% | 13−11.9%100% | 14+13.8%100% | 12+15.7%100% | 11—100% | |
| Cost of revenue | 45r46+14.5%72.5% | 39r36+30.9%75.1% | 30r29+3.7%80.5% | 29+39.3%77.6% | 21+86.7%70.5% | 11+12.5%65.0% | 9.9−9.3%79.1% | 11+26.5%76.8% | 8.6+14.3%69.1% | 7.5—70.0% | |
| Gross profit | 17r16+30.9%27.5% | 13r16+79.3%24.9% | 7.3r7.8−12.9%19.5% | 8.4−3.8%22.4% | 8.7+45.1%29.5% | 6.0+129%35.0% | 2.6−20.5%20.9% | 3.3−14.5%23.2% | 3.9+18.8%30.9% | 3.2—30.0% | |
| Research and development | 4.1+6.6%6.6% | 3.80.0%7.3% | 3.8+26.3%10.3% | 3.0+35.9%8.1% | 2.2+42.3%7.6% | 1.6−16.0%9.2% | 1.9−9.1%14.9% | 2.1+18.5%14.5% | 1.7+11.7%13.9% | 1.6—14.4% | |
| Selling, general and administrative | 10+44.1%16.8% | 7.2−4.2%13.8% | 7.5−0.6%20.2% | 7.6+94.6%20.3% | 3.9+32.8%13.2% | 2.9−17.2%17.1% | 3.5+8.8%28.3% | 3.3+12.8%22.9% | 2.9−2.3%23.1% | 3.0—27.4% | |
| Total costs and expenses | 59r60+15.6%95.5% | 51r48+21.3%97.9% | 42r42—113% | — | — | — | — | — | — | — | |
| Operating income | 2.6r1.6+29.8%4.2% | 2.0r5.1—3.8% | −4.1r−3.5—−11.0% | −2.3−188%−6.1% | 2.6+72.3%8.7% | 1.5—8.7% | −2.8—−22.4% | −2.0—−14.3% | −0.8—−6.2% | −1.3—−11.8% | |
| Interest and finance income | 0.2—0.3% | — | — | — | — | — | — | — | — | — | |
| Interest expense and finance costs | — | 0.7−20.0%1.3% | 0.8+119%2.2% | 0.4−66.9%1.0% | 1.2+133%3.9% | 0.5+136%2.9% | 0.2+262%1.7% | 0.1+70.6%0.4% | 0.0+127%0.3% | 0.0—0.1% | |
| Other non-operating income (expense) | — | — | — | — | — | — | — | — | 0.0—0.1% | — | |
| Income before tax | 2.9r1.9+117%4.6% | 1.3r4.5—2.5% | −4.9r−4.4—−13.2% | −2.6−212%−7.1% | 2.4+138%8.0% | 1.0—5.8% | −3.0—−24.0% | −2.1—−14.7% | −0.8—−6.3% | −1.3—−11.9% | |
| Income tax | 0.1−67.8%0.1% | 0.2+3683%0.4% | 0.0—0.0% | −0.0−146%−0.0% | 0.0—0.1% | — | — | 0—0.0% | 0—0.0% | — | |
| Net income attributable to shareholders | 2.8r1.8+156%4.5% | 1.1r4.2—2.1% | −4.9r−4.4—−13.2% | −2.6−213%−7.0% | 2.3+135%7.9% | 1.0—5.8% | −3.0—−24.0% | −2.1—−14.7% | −0.8—−6.3% | −1.3—−11.9% | |
| Earnings per share, basic | 0.04r0.03+100%— | 0.02r0.07—— | -0.10r-0.09—— | -0.05−200%— | 0.05+66.7%— | 0.03—— | -0.08—— | -0.06—— | -0.03—— | -0.04—— | |
| Earnings per share, diluted | 0.04r0.02+100%— | 0.02r0.07—— | -0.10r-0.09—— | -0.05−200%— | 0.05+66.7%— | 0.03—— | -0.08—— | -0.06—— | -0.03—— | -0.04—— | |
| Shares, weighted average (basic) | 70+12.8%— | 62+25.8%— | 50+0.9%— | 49+9.1%— | 45+18.0%— | 38+4.3%— | 37—— | — | — | — | |
| Shares, weighted average (diluted) | 73+11.6%— | 65+31.2%— | 50+0.9%— | 49+4.4%— | 47+22.0%— | 39+5.3%— | 37+8.0%— | 34+8.1%— | 31+1.4%— | 31—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 1.3−8.6%2.8% | 1.4−18.2%3.1% | 1.7−21.2%5.5% | 2.2+233%6.5% | 0.7−31.3%2.3% | 1.0−19.8%7.1% | 1.2−11.2%12.7% | 1.3−31.2%20.5% | 2.0+9.9%31.2% | 1.8—36.7% | |
| Receivables | 6.8+40.4%14.7% | 4.9+40.4%10.7% | 3.5−26.8%11.1% | 4.7+20.2%14.1% | 3.9+34.3%13.9% | 2.9+202%21.7% | 1.0+17.0%10.3% | 0.8−25.7%12.6% | 1.1+157%17.8% | 0.4—9.0% | |
| Inventory | 15r19−4.7%32.1% | 16r20+83.4%34.4% | 8.5r10−3.7%27.2% | 8.8+45.0%26.3% | 6.1+40.4%21.5% | 4.3+69.9%32.1% | 2.6+13.9%27.3% | 2.2+61.9%34.1% | 1.4r1.1+79.4%22.1% | 0.8—15.9% | |
| Other current assets | 2.1−23.6%4.6% | 2.8+159%6.2% | 1.1+24.9%3.4% | 0.9−4.8%2.6% | 0.9+50.2%3.2% | 0.6+127%4.5% | 0.3−2.2%2.8% | 0.3+61.5%4.2% | 0.2r0.4−61.8%2.7% | 0.4—9.1% | |
| Current assets | 25r29+1.8%54.2% | 25r29+67.0%54.5% | 15r16−11.1%47.1% | 17+43.3%49.5% | 12+31.3%40.9% | 8.8+77.2%65.3% | 5.0+6.3%53.2% | 4.7+1.4%71.4% | 4.6+34.9%73.8% | 3.4—70.8% | |
| Property, plant and equipment | 14+12.5%30.9% | 13+46.9%28.1% | 8.7+9.0%27.6% | 7.9+68.7%23.7% | 4.7+64.3%16.6% | 2.9+27.2%21.2% | 2.3+20.9%24.1% | 1.9+14.8%28.4% | 1.6+16.4%25.9% | 1.4—28.8% | |
| Right-of-use (leased) assets | 6.9−12.7%14.9% | 7.9+0.1%17.5% | 7.9−11.9%25.2% | 9.0−25.6%26.8% | 12+561%42.5% | 1.8−13.8%13.5% | 2.1—22.6% | — | — | — | |
| Total assets | 46r50+2.4%100% | 45r50+44.6%100% | 31r33−6.5%100% | 34+18.2%100% | 28+110%100% | 14+44.5%100% | 9.4+42.7%100% | 6.6+4.8%100% | 6.3+29.4%100% | 4.8—100% | |
| Accounts payable | 4.1−54.9%8.8% | 9.1+45.3%20.1% | 6.3−1.6%20.0% | 6.4+78.4%19.0% | 3.6+67.7%12.6% | 2.1+21.6%15.7% | 1.7+8.7%18.7% | 1.6+54.9%24.5% | 1.0+55.2%16.6% | 0.7—13.8% | |
| Debt due within a year | — | — | — | — | — | 0.50.0%3.7% | 0.5—5.3% | — | — | — | |
| Current liabilities | 14−46.0%30.0% | 26+65.3%56.8% | 16r16+12.7%49.7% | 14r17+88.5%41.2% | 7.3r8.7+8.2%25.9% | 6.8+53.9%50.1% | 4.4+21.2%47.0% | 3.6+79.7%55.4% | 2.0+56.1%32.3% | 1.3—26.8% | |
| Long-term debt | — | — | — | 1.00.0%3.0% | 1.0+5.0%3.5% | 1.0—7.0% | — | — | — | — | |
| Lease liabilities (non-current) | 7.8−13.7%16.8% | 9.0−1.3%19.9% | 9.2−6.8%29.2% | 9.8−16.0%29.3% | 12r10+609%41.2% | 1.7−18.9%12.2% | 2.0—21.7% | — | — | — | |
| Non-current liabilities | 18+99.2%39.8% | 9.3−39.7%20.5% | 15r15+9.4%49.1% | 14r11+3.6%41.9% | 14r12+238%47.9% | 4.0+16.6%29.7% | 3.5+123%36.8% | 1.5+53.3%23.6% | 1.0+34.0%16.1% | 0.8—15.6% | |
| Retained earnings | −102r−99—−220% | −105r−100—−232% | −106r−105—−339% | −100—−298% | −97—−343% | −100—−737% | −101—−1075% | −98—−1488% | −96—−1527% | −95—−1960% | |
| Shareholders' equity | 14r18+36.0%30.2% | 10r15+2560%22.7% | 0.4r1.9−91.7%1.2% | 4.7r5.6−37.3%13.9% | 7.5+173%26.3% | 2.7+80.8%20.2% | 1.5+9.2%16.1% | 1.4−57.2%21.1% | 3.2+15.8%51.6% | 2.8—57.6% | |
| Total liabilities and equity | 46r50+2.4%100% | 45r50+44.6%100% | 31r33−6.5%100% | 34+18.2%100% | 28+110%100% | 14+44.5%100% | 9.4+42.7%100% | 6.6+4.8%100% | 6.3+29.4%100% | 4.8—100% | |
| Shares outstanding | 71+0.7%— | 70+41.3%— | 50+0.6%— | 49+0.9%— | 49+27.9%— | 38+0.2%— | 38r38+12.5%— | 34+0.2%— | 34+8.4%— | 31—— | |
| Cash-flow statement | |||||||||||
| Depreciation and amortization | 0.9−3.3%1.4% | 0.9+25.1%1.8% | 0.7+30.9%2.0% | 0.6+24.9%1.5% | 0.5+26.8%1.5% | 0.4+13.7%2.1% | 0.3−2.2%2.5% | 0.3−6.4%2.3% | 0.3−43.6%2.8% | 0.6—5.7% | |
| Share-based compensation | 0.6−20.7%0.9% | 0.7−6.2%1.4% | 0.8+23.7%2.1% | 0.6+291%1.7% | 0.2−17.9%0.5% | 0.2−19.4%1.1% | 0.2+18.6%1.9% | 0.2+11.5%1.4% | 0.2−11.6%1.5% | 0.2—1.9% | |
| Cash from operating activities | −8.6−535%−13.8% | 2.0—3.8% | −2.0—−5.4% | −1.7−171%−4.4% | 2.3—7.9% | −2.1—−12.0% | −2.8—−22.2% | −1.3—−9.5% | −1.0—−7.7% | −0.2—−2.2% | |
| Capital expenditure | — | −4.6—−8.7% | −1.1—−2.8% | −2.8—−7.6% | −1.9—−6.4% | −0.9—−5.1% | −0.7—−5.9% | −0.2—−1.1% | −0.2—−1.7% | −0.1—−1.2% | |
| Cash from investing activities | −2.1—−3.5% | −4.6—−8.7% | −1.1—−2.8% | −2.8—−7.6% | −1.9—−6.4% | −0.9—−5.1% | −0.7—−5.9% | −0.2—−1.1% | −0.1—−0.6% | −0.2—−1.5% | |
| Shares issued | 0.3−84.5%0.5% | 2.1—4.0% | — | — | — | — | 1.7—13.4% | — | 1.0+1.2%8.0% | 1.0—9.2% | |
| Cash from financing activities | 11+366%17.1% | 2.3−12.3%4.3% | 2.6−56.8%7.0% | 6.0—16.1% | −0.7−128%−2.5% | 2.7−19.7%15.8% | 3.4+277%26.9% | 0.9−26.2%6.3% | 1.2+32.7%9.7% | 0.9—8.4% | |
| Change in cash | −0.1—−0.2% | −0.3—−0.6% | −0.5−130%−1.2% | 1.5—4.1% | −0.3—−1.0% | −0.2—−1.4% | −0.2—−1.2% | −0.6−447%−4.3% | 0.2−65.1%1.4% | 0.5—4.7% | |
| Report | 10-K/A | 10-K/A | 10-K/A | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 61−2.0%100% | 20+38.1%100% | 15−24.7%100% | 13−11.4%100% | 12*−0.7%100% | 15−13.5%100% | 20+56.1%100% | 15+48.2%100% | 13*+56.9%100% | 17—100% | 13—100% | 9.9—100% | 8.0*—100% | |
| Cost of revenue | 42−11.8%68.3% | 12+10.0%60.7% | 11r11−22.8%69.7% | 9.8r9.6−11.7%75.6% | 8.9r9.0*−20.1%71.6% | 11r11+0.3%76.2% | 14r14+48.6%67.9% | 11r11+76.4%75.8% | 11r9.8*+38.3%89.0% | 11r11—65.7% | 9.3—71.3% | 6.3—63.7% | 8.1r7.5*—101% | |
| Gross profit | 19+29.3%31.7% | 7.9+128%39.3% | 4.7r4.7−28.8%30.3% | 3.2r3.3−10.4%24.4% | 3.5r3.4*+157%28.4% | 3.5r3.4−39.9%23.8% | 6.5r5.9+74.6%32.1% | 3.5r3.4−1.3%24.2% | 1.4r2.8*—11.0% | 5.8r6.1—34.3% | 3.7—28.7% | 3.6—36.3% | −0.1r0.5*—−0.9% | |
| Research and development | 4.1−1.0%6.7% | 1.10.0%5.4% | 0.9−0.8%6.2% | 1.0+2.4%8.0% | 1.0*−5.1%8.3% | 1.1+11.5%7.4% | 1.0+10.5%4.7% | 1.0+11.9%7.0% | 1.1*+39.0%8.7% | 1.0—5.8% | 0.9—6.6% | 0.9—9.2% | 0.8*—9.8% | |
| Selling, general and administrative | 12+14.0%18.9% | 2.8−8.4%13.9% | 3.7+22.2%24.0% | 2.8+32.8%21.6% | 2.2*+16.6%17.7% | 3.1+58.7%21.0% | 3.0+64.7%14.8% | 2.1+35.2%14.4% | 1.9*+19.9%15.1% | 1.9—11.5% | 1.8—14.0% | 1.6—15.8% | 1.6*—19.8% | |
| Total costs and expenses | 58−5.5%95.5% | 16+5.6%81.8% | 16r15−8.5%102% | 14r14−3.5%107% | 12r12*−15.9%97.8% | 16r16+10.4%107% | 17r18+39.8%83.7% | 14r15+60.4%98.4% | 15r13*—115% | 14r14—83.9% | 12—93.4% | 9.0—91.0% | — | |
| Operating income | 3.7+437%6.0% | 4.0—20.0% | 0.0r0.1−99.1%0.2% | −0.7r−0.5−266%−5.2% | 0.3r0.2*—2.4% | −0.7r−0.8−124%−4.6% | 2.6r1.9+145%12.6% | 0.4r0.3−63.4%2.8% | −1.6r−0.2*—−12.8% | 2.9r3.2—17.0% | 1.0—8.0% | 1.1—11.3% | −2.4r−1.9*—−30.5% | |
| Interest and finance income | — | — | — | — | 0*—0.0% | 0.2—1.3% | 0.2—1.0% | — | — | — | — | — | — | |
| Interest expense and finance costs | — | — | — | — | — | — | — | 0.2−19.3%1.2% | — | 0.2—0.9% | 0.2—1.5% | 0.2—2.2% | 0.2*—2.8% | |
| Income before tax | 2.7+119%4.4% | 3.9—19.3% | −0.3r−0.2−107%−1.7% | −0.9r−0.8−505%−7.2% | −0.0r−0.2*—−0.4% | −1.0r−1.1−137%−7.0% | 3.7r3.1+334%18.2% | 0.2r0.1−74.1%1.6% | −1.7r−0.3*—−13.7% | 2.7r3.0—16.1% | 0.9—6.6% | 0.9—9.0% | −2.7r−2.1*—−33.3% | |
| Income tax | — | 0.2—1.1% | — | — | −0.3*—−2.5% | 0*—0.0% | 0.4—1.9% | — | — | — | — | — | — | |
| Net income attributable to shareholders | 2.8+365%4.5% | 3.7—18.2% | −0.3r−0.2−108%−1.7% | −0.9r−0.8−505%−7.2% | 0.3r0.2*—2.2% | −1.0r−1.1−137%−7.0% | 3.3r2.7+533%16.3% | 0.2r0.1—1.6% | −1.9r−0.6*—−15.5% | 2.7r3.0—16.1% | 0.5r0.9—4.0% | −0.2r0.9—−2.0% | −2.7r−2.1*—−33.4% | |
| Earnings per share, basic | — | 0.05—— | 0.00−100%— | -0.01—— | — | -0.01r-0.02−125%— | 0.05r0.04+150%— | 0.00−100%— | — | 0.04—— | 0.02—— | 0.02—— | — | |
| Earnings per share, diluted | — | 0.05—— | 0.00−100%— | -0.01—— | — | -0.01r-0.02−125%— | 0.05r0.04+400%— | 0.00−100%— | — | 0.04—— | 0.01—— | 0.02—— | — | |
| Shares, weighted average (basic) | 71+0.2%— | 71+0.2%— | 71+0.6%— | 71+0.7%— | — | 71+0.9%— | 70+23.9%— | 70+33.1%— | — | 70—— | 57—— | 53—— | — | |
| Shares, weighted average (diluted) | 71+1.4%— | 71+1.4%— | 71−2.7%— | 71−2.8%— | — | 71−2.0%— | 73+23.6%— | 73+25.2%— | — | 72—— | 59—— | 58—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 1.3—2.9% | 1.3+196%2.9% | 1.0−74.5%2.3% | 0.6−68.5%1.3% | 1.3−8.6%2.8% | 0.4−85.3%0.9% | 4.1+74.2%6.9% | 1.8−10.0%3.2% | 1.4−18.2%3.1% | 2.9—6.1% | 2.4—5.8% | 2.0—5.2% | 1.7—5.5% | |
| Receivables | 8.4—18.8% | 8.4−13.9%18.8% | 9.3−15.4%20.2% | 6.4−29.8%14.5% | 6.8+40.4%14.7% | 9.7+11.2%19.3% | 11+86.3%18.4% | 9.1+73.8%15.9% | 4.9+40.4%10.7% | 8.7—18.2% | 5.9—14.5% | 5.2—13.6% | 3.5—11.1% | |
| Inventory | 12—26.1% | 12−23.4%26.1% | 13r13−35.5%27.7% | 14r18−37.2%31.3% | 15r19−4.7%32.1% | 15r19+0.6%30.1% | 20+42.9%33.1% | 22+65.0%38.4% | 16r20+83.4%34.4% | 15—31.3% | 14—34.0% | 13—34.5% | 8.5r10—27.2% | |
| Other current assets | 2.0—4.6% | 2.0−46.4%4.6% | 1.9−49.2%4.2% | 1.9−38.4%4.3% | 2.1−23.6%4.6% | 3.8+23.7%7.5% | 3.8+80.4%6.3% | 3.1+107%5.4% | 2.8+159%6.2% | 3.1—6.4% | 2.1—5.1% | 1.5—3.9% | 1.1—3.4% | |
| Current assets | 23—52.3% | 23−19.9%52.3% | 25r25−35.2%54.3% | 23r26−37.0%51.4% | 25r29+1.8%54.2% | 29r33−2.4%57.8% | 39+59.8%64.7% | 36+62.6%63.0% | 25r29+67.0%54.5% | 30—61.9% | 24—59.4% | 22—57.3% | 15r16—47.1% | |
| Property, plant and equipment | 15—33.8% | 15+7.7%33.8% | 15+9.1%32.0% | 15+12.5%33.5% | 14+12.5%30.9% | 14+36.2%27.7% | 14+46.4%22.6% | 13+48.8%23.0% | 13+46.9%28.1% | 10—21.3% | 9.3—22.7% | 8.8—22.9% | 8.7—27.6% | |
| Right-of-use (leased) assets | 6.1—13.8% | 6.1−15.5%13.8% | 6.3−16.9%13.7% | 6.6−17.6%15.0% | 6.9−12.7%14.9% | 7.3−9.9%14.4% | 7.6+4.1%12.7% | 8.0+5.1%14.0% | 7.9+0.1%17.5% | 8.1—16.8% | 7.3—17.9% | 7.6—19.8% | 7.9—25.2% | |
| Total assets | 44—100% | 44−11.6%100% | 46r46−22.8%100% | 44r48−22.8%100% | 46r50+2.4%100% | 50r54+4.6%100% | 60+46.8%100% | 57+48.1%100% | 45r50+44.6%100% | 48—100% | 41—100% | 39—100% | 31r33—100% | |
| Accounts payable | 4.5—10.2% | 4.5−6.2%10.2% | 5.0−27.9%10.7% | 4.7−49.0%10.6% | 4.1−54.9%8.8% | 4.8−26.5%9.6% | 6.9+23.6%11.5% | 9.2+47.5%16.1% | 9.1+45.3%20.1% | 6.6—13.7% | 5.6—13.7% | 6.2—16.1% | 6.3—20.0% | |
| Current liabilities | 13—30.3% | 13−24.7%30.3% | 26+15.4%56.2% | 13−61.4%28.8% | 14−46.0%30.0% | 18−23.3%35.6% | 23+63.7%37.6% | 33+170%57.7% | 26+65.3%56.8% | 23—48.5% | 14—33.7% | 12—31.6% | 16r16—49.7% | |
| Lease liabilities (non-current) | 6.7—15.2% | 6.7−17.3%15.2% | 7.1−16.6%15.3% | 7.4−14.8%16.9% | 7.8−13.7%16.8% | 8.1−12.9%16.2% | 8.5−2.7%14.1% | 8.7−2.2%15.3% | 9.0−1.3%19.9% | 9.3—19.5% | 8.7—21.3% | 8.9—23.2% | 9.2—29.2% | |
| Non-current liabilities | 14—32.0% | 14−24.6%32.0% | 7.3−62.2%15.7% | 18+102%41.2% | 18+99.2%39.8% | 19+97.0%37.6% | 19+26.9%32.1% | 9.0−41.6%15.8% | 9.3−39.7%20.5% | 9.6—20.0% | 15—37.1% | 15—39.9% | 15r15—49.1% | |
| Retained earnings | −100—−225% | −100—−225% | −103r−103—−224% | −103r−99—−235% | −102r−99—−220% | −103r−99—−204% | −98—−163% | −100—−176% | −105r−100—−232% | −100—−208% | −103—−252% | −104—−270% | −106r−105—−339% | |
| Shareholders' equity | 17—37.7% | 17+24.2%37.7% | 13r13−9.4%28.1% | 13r17+23.5%29.9% | 14r18+36.0%30.2% | 13r17+13.3%26.8% | 14r18+59.6%23.9% | 11r15+355%18.7% | 10r15+2560%22.7% | 12r15—24.8% | 9.0r12—22.0% | 2.3r5.0—6.1% | 0.4r1.9—1.2% | |
| Total liabilities and equity | 44—100% | 44−11.6%100% | 46r46−22.8%100% | 44r48−22.8%100% | 46r50+2.4%100% | 50r54+4.6%100% | 60+46.8%100% | 57+48.1%100% | 45r50+44.6%100% | 48—100% | 41—100% | 39—100% | 31r33—100% | |
| Shares outstanding | 71—— | 71+0.2%— | 71+0.2%— | 71+0.8%— | 71+0.7%— | 71+0.8%— | 70+0.9%— | 70+27.8%— | 70+41.3%— | 70—— | 70—— | 55—— | 50—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 1.2+29.4%1.9% | 0.3*+39.1%1.6% | 0.3*+43.6%2.1% | 0.3+38.5%2.4% | 0.2*−3.1%1.8% | 0.2*−2.6%1.5% | 0.2*−4.3%1.1% | 0.2−3.4%1.5% | 0.2*+4.6%1.8% | 0.2*—1.4% | 0.2*—1.8% | 0.2—2.4% | 0.2*—2.7% | |
| Share-based compensation | 0.5−26.9%0.7% | 0.1*−31.1%0.4% | 0.1r0.1*−34.2%0.5% | 0.1r0.1−35.4%0.6% | 0.2*−16.9%1.7% | 0.1*−23.8%0.8% | 0.1*−23.6%0.6% | 0.1−20.6%0.9% | 0.2*+37.8%2.0% | 0.2*—0.9% | 0.2*—1.2% | 0.2—1.6% | 0.2*—2.2% | |
| Cash from operating activities | 10—16.8% | 6.7*—33.3% | 0.2*—1.2% | 1.5—11.7% | 1.8*−16.9%14.6% | −2.5*−160%−17.2% | −0.7*—−3.2% | −7.2—−49.4% | 2.2*—17.4% | 4.2*—24.9% | −0.6*—−4.3% | −3.9—−39.1% | −2.7*—−33.1% | |
| Capital expenditure | — | — | — | — | — | — | — | — | −2.6*—−20.6% | −1.4*—−8.3% | −0.5*—−3.7% | −0.1—−0.9% | −0.2*—−2.5% | |
| Cash from investing activities | −2.0—−3.3% | −0.5*—−2.7% | −0.5*—−3.1% | −0.5−497%−4.1% | −0.5*—−3.6% | −0.4*—−2.9% | −1.4*—−6.9% | 0.1—0.9% | −2.6*—−20.6% | −1.4*—−8.3% | −0.5*—−3.7% | −0.1—−0.9% | −0.2*—−2.5% | |
| Shares issued | 0.1−82.9%0.1% | 0*−100%0.0% | 0.0*−95.5%0.1% | 0.0+300%0.1% | 0.0*−58.0%0.3% | 0.0*−7.7%0.2% | 0.2*—1.2% | 0.0−99.8%0.0% | 0.1*—0.7% | 0.0*—0.2% | −0.0*—−0.3% | 2.0—20.2% | — | |
| Cash from financing activities | −7.4−174%−12.2% | −6.0*—−29.5% | 0.8*−82.7%4.9% | −1.7−123%−13.2% | −0.5*—−4.1% | −0.8*—−5.1% | 4.4*+215%21.4% | 7.5+77.0%51.3% | −1.1*−133%−8.8% | −2.2*—−13.2% | 1.4*—10.6% | 4.2—42.9% | 3.4*—42.2% | |
| Change in cash | 0.8—1.4% | 0.2*—1.1% | 0.5*−79.4%3.1% | −0.7−275%−5.5% | 0.9*—6.9% | −3.7*−749%−25.2% | 2.3*+574%11.3% | 0.4+37.8%2.8% | −1.5*−384%−12.1% | 0.6*—3.4% | 0.3*—2.6% | 0.3—3.0% | 0.5*—6.7% | |
| Report | Worked out | 10-Q | 10-Q/A | 10-Q/A | 10-Q | 10-Q/A | 10-Q | 10-Q/A | 10-Q/A | 10-Q | 10-Q | 10-Q | 10-K/A | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What Solesence, Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Products and services
- Product(total)$62 M100%+19%
- Consumer Products$55 M88%+24%
- Personal Care ingredients$6 M10%-7.2%
- Advanced Materials$1 M1.4%-25%
- Product and Service, Other$0 M0.4%-41%
Countries and regions
- Non-US(total)$5 M8.3%+184%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Events at Solesence, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Delisting notice 1 · Financial statements withdrawn 1 · Directors and officers 4 · Material agreement 6 · Bylaws or fiscal year changed 3 · Shareholder vote 3 · Results announced 8
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Delisting notice | 8-K | |
| Financial statements withdrawn | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Directors and officersMaterial agreement | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Directors and officersMaterial agreement | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Bylaws or fiscal year changed | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Bylaws or fiscal year changed | 8-K | |
| Bylaws or fiscal year changedShareholder vote | 8-K | |
| Shareholder vote | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026
Acquisitions and funding#
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2017 | $1 M | Private placement after listing | Under $2 million | 1 | equity | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
H-1B hiring at Solesence, Inc.#
1 labor condition applications certified in fiscal 2025 for 1 positions, at a median wage of $79 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| QC Chemist IIChemists | 1 | $79 K |
Where: Romeoville, IL 1
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Solesence Inc.
How Solesence, Inc. compares in FMCG
- Market cap$59 M · higher than 18% of 110
- Revenue$62 M · higher than 10% of 104
- Net margin4.5% · higher than 38% of 103
- Revenue growth18.6% · higher than 93% of 46
- P/E ratio21.3× · lower than 52% of 61
- Price / sales1.0× · lower than 76% of 72
- Price / book4.2× · lower than 34% of 71
- FCF yield-4.4% · higher than 12% of 34
Peer comparison · FMCG
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Solesence, Inc.🇺🇸 | $59 M | 21.3× | 4.5% | +18.6% |
| The Procter & Gamble Company🇺🇸 | $372.2 B | 23.2× | 18.2% | +3.3% |
| L'Oréal S.A.🇫🇷 | $241.7 B | 33.3× | 13.9% | +5.5% |
| Unilever PLC🇬🇧 | $135.7 B | 12.7× | 18.8% | +0.3% |
| Colgate-Palmolive Company🇺🇸 | $74.8 B | 36.4× | 9.7% | +1.4% |
| Hindustan Unilever Limited🇮🇳 | $52.2 B | 32.2× | 23.6% | — |
| Reckitt Benckiser Group PLC🇬🇧 | $44.3 B | 10.2× | 22.4% | +3.3% |
| Haleon plc🇬🇧 | $42.6 B | 19.4× | 15.1% | +1.2% |
| The Estée Lauder Companies Inc.🇺🇸 | $39.6 B | 107.6× | 2.4% | +5.0% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
Sources and freshness
- Market cap:
- Oct 30, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As of December 31, 2025
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Solesence, Inc.? Verify and update this profile — free
Show Solesence, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.